Newsletter Subject

Racial, Ethnic Disparities Persist in OUD Treatment

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, May 10, 2023 10:51 PM

Email Preheader Text

Daily Headlines Wednesday, May 10, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Wednesday, May 10, 2023 Today's Top Stories for {NAME} [PSYCHIATRY]( [Racial, Ethnic Disparities Persist in OUD Treatment]( [PUBLIC HEALTH & POLICY]( [All Thumbs Up for OTC Birth Control Pill at FDA Advisory Meeting]( [NEUROLOGY]( [Sarepta's Gene Therapy Does Not Have 'Unambiguous Evidence,' FDA Staff Says]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Diagnosis and First-Line Treatment]( [INFECTIOUS DISEASE]( [Hyperbaric Oxygen for Long COVID? Heart Ultrasounds Offer Limited Support]( [ONCOLOGY/HEMATOLOGY]( [Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Novel Drug Checks All the Boxes as Dry Eye Treatment]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Resistant and Refractory CMV Management]( [SPECIAL REPORTS]( [Gun Owner Advances Doc Group's Gun Safety Initiative]( [SPECIAL REPORTS]( [As the COVID PHE Ends, Here's What Doctors Are Carrying Forward]( [GASTROENTEROLOGY]( [Prophylactic Antibiotics of Little Benefit in Severe Alcoholic Hepatitis]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [ALLERGY & IMMUNOLOGY]( [FDA Staff Grapples With Absent Clinical Efficacy Data for Nasal Epinephrine]( [SURGERY]( [Palliative Care No Boon for Patients Undergoing Abdominal Surgery for Cancer]( [INFECTIOUS DISEASE]( [What Will Change Now That the Public Health Emergency Is Ending? Experts Weigh In]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [Low-Dose Pilocarpine Improves Vision in Vehicle-Controlled Presbyopia Trials]( [OB/GYN]( [Postpartum Hemorrhage Risks Averted With Monitoring, Bundled Treatment]( [NEUROLOGY]( [Brain Amyloid Seen in Young Men With Subconcussive Trauma]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( [PSYCHIATRY]( [Social Media Misery in Kids; ADHD Video Game for Adults; Most Depressed U.S. State]( [SPECIAL REPORTS]( [AI Poses Serious Threats to Health and Human Existence, Researchers Say]( CME SPOTLIGHT [Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams]( # Weekly Survey [Mask Up in Long COVID Trial?]( Participants in a long COVID trial at Stanford are upset with researchers for [not masking during clinic visits]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-05-10&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.